About US
Contact us
-
Bayer's Kovaltry receives FDA approval to treat haemophilia AGerman pharmaceutical company Bayer has received approval from the US Food and Drug Administration (FDA) for Kovaltry Antihemophilic Factor (Recombinant) for the treatment of children and adults with2016/3/23
-
Sanofi, DiCE Molecules to develop oral treatments to replace monoclonal antibodiesFrench drugmaker Sanofi has collaborated with DiCE Molecules to discover potential therapeutics based on unique small molecule discovery platform. The potential new oral treatments would replace mono2016/3/23
-
J&J, BMS are delivering solid sales from new meds. The rest of Big Pharma, not so much: ForbesHow many drugmakers are delivering valuable new meds to the marketplace, saleswise? All too few, says innovation researcher and ex-Big Pharma manager Bernard Munos. In fact, the only two Big Pharmas w2016/3/22
-
Hey, pharma, you're not spending enough on advertising, one expert saysThink pharma spends too much on advertising? Think again, says one expert. Drugmakers need to spread more money into digital channels just to keep up with consumers' growing exposure to ads, says Gayl2016/3/22
-
J&J's Stelara, playing defense in psoriasis, posts more positive Crohn's dataJohnson and Johnson's ($JNJ)Stelarais facing fierce new competition in the psoriasis arena. But the New Jersey drugmaker is looking for ways the med can make its mark in other disease areas, and it's2016/3/21
-
Senators lambaste Turing for 'unethical' price hikes at latest drug price hearingTuring Pharmaceuticalswas front and center again at a recent Senate hearing over drug price increases, and for the most part, it was the same old song and dance. The drugmaker came under fire by a bip2016/3/21
-
EU approves €10m funds for research on Zika virusThe European Commission is providing €10m in funding to support research on the Zika virus, which is currently found to be active in several parts of Latin America. In November last year, preliminary2016/3/18
-
Pharmapack 2016: Green Pharmaceutical PackagingGerresheimer has released the first eco-friendly plastic containers for pharmaceutical and cosmetic applications, BioPack. It makes an excellent substitute for traditional PE and PET because it has t2016/3/18
-
Takeda, Frazier Healthcare form new company to develop urology and gynaecology therapeuticsTakeda Pharmaceutical and Frazier Healthcare Partners have set up a new biopharmaceutical company to develop new therapeutics in urology and gynaecology. Known as Outpost Medicine, the new company ha2016/3/17
-
Pfizer's Xalkori receives FDA approval to treat ROS1-positive metastatic non-small cell lung cancerPfizer has received approval from the US Food and Drug Administration (FDA) for a supplemental new drug application (sNDA) for Xalkori (crizotinib) to treat patients with ROS1-positive metastatic non-2016/3/17